A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Site DK45005 Rigshospitalet, Copenhagen

Site BE32009 Univ.Ziekenhuis Antwerpen, Edegem

Site BE32011 U.Z. Leuven, Leuven

Site DK45004 Børnelægen i Køge, Koege

Site NO47001 Haukeland Sykehus, Bergen

Site DK45002 Kolding Sygehus, Kolding

Site DK45001 Uni Hosp of Aarhus, Skejby, Aarhus

Site BE32004 AZ Groeninge, Campus Vercruyss, Kortrijk

Site BE32003 Gent University Hospital, Ghent

Site DK45003 Aalborg Sygehus Nord, Aalborg

Site RS38010 Mother and Child Health Care, Belgrade

Site PL48003 Uniwersyteckie Centrum Kliniczne, Gdansk

Site PL48001 Pomnik-Centrum Zdrowia Dziecka, Warsaw